IPAROMLIMAB AND TUVONRALIMAB INJECTION
Clinical trials for IPAROMLIMAB AND TUVONRALIMAB INJECTION explained in plain language.
Never miss a new study
Get alerted when new IPAROMLIMAB AND TUVONRALIMAB INJECTION trials appear
Sign up with your email to follow new studies for IPAROMLIMAB AND TUVONRALIMAB INJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple-Threat attack on tough liver cancer
Disease control Recruiting nowThis study is testing a new three-part treatment for people with advanced liver cancer that has spread into a major vein in the liver. The treatment combines immunotherapy, a targeted drug, and chemotherapy delivered directly to the liver. The main goal is to see if this combinat…
Matched conditions: IPAROMLIMAB AND TUVONRALIMAB INJECTION
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Three-Pronged attack on Tough-to-Treat colon cancer
Disease control Recruiting nowThis early-stage study is testing a new three-part treatment for advanced colorectal cancer that has stopped responding to standard therapies. It combines an immunotherapy drug, a targeted cancer drug, and a personalized cell therapy made from the patient's own immune cells. The …
Matched conditions: IPAROMLIMAB AND TUVONRALIMAB INJECTION
Phase: EARLY_PHASE1 • Sponsor: JIANG LONGWEI • Aim: Disease control
Last updated Mar 09, 2026 14:26 UTC